de BlackRock Rigel Pharmaceuticals RIGL Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 75.9 M | Comprar |
1,939,818
+170,911
| +10% | +USD 5.27 M | ﹤0.01% | 2389 |
|
|
2026
Q1 | USD 47.8 M | Comprar |
1,768,907
+104,697
| +6% | +USD 3.52 M | ﹤0.01% | 2532 |
|
|
2025
Q4 | USD 71.3 M | Vender |
1,664,210
-60,688
| -4% | -USD 2.29 M | ﹤0.01% | 2307 |
|
|
2025
Q3 | USD 48.9 M | Comprar |
1,724,898
+99,128
| +6% | +USD 2.97 M | ﹤0.01% | 2513 |
|
|
2025
Q2 | USD 30.5 M | Vender |
1,625,770
-106,834
| -6% | -USD 2.03 M | ﹤0.01% | 2778 |
|
|
2025
Q1 | USD 31.2 M | Vender |
1,732,604
-15,503
| -0.9% | -USD 315 k | ﹤0.01% | 2660 |
|
|
2024
Q4 | USD 29.4 M | Comprar |
1,748,107
+186,664
| +12% | +USD 3.58 M | ﹤0.01% | 2795 |
|
|
2024
Q3 | USD 25.3 M | Comprar |
1,561,443
+48,544
| +3% | +USD 571 k | ﹤0.01% | 2885 |
|
|
2024
Q2 | USD 12.4 M | Comprar |
1,512,899
+33,025
| +2% | +USD 346 k | ﹤0.01% | 3252 |
|
|
2024
Q1 | USD 21.9 M | Vender |
1,479,874
-39,934
| -3% | -USD 538 k | ﹤0.01% | 2944 |
|
|
2023
Q4 | USD 22 M | Comprar |
1,519,808
+78,458
| +5% | +USD 802 k | ﹤0.01% | 2962 |
|
|
2023
Q3 | USD 15.6 M | Vender |
1,441,350
-20,409
| -1% | -USD 246 k | ﹤0.01% | 3081 |
|
|
2023
Q2 | USD 18.9 M | Comprar |
1,461,759
+49,543
| +4% | +USD 670 k | ﹤0.01% | 3077 |
|
|
2023
Q1 | USD 18.6 M | Vender |
1,412,216
-55,890
| -4% | -USD 888 k | ﹤0.01% | 3012 |
|
|
2022
Q4 | USD 22 M | Vender |
1,468,106
-149,918
| -9% | -USD 1.37 M | ﹤0.01% | 2980 |
|
|
2022
Q3 | USD 19.1 M | Vender |
1,618,024
-24,748
| -2% | -USD 335 k | ﹤0.01% | 3058 |
|
|
2022
Q2 | USD 18.6 M | Vender |
1,642,772
-14,593
| -0.9% | -USD 293 k | ﹤0.01% | 3127 |
|
|
2022
Q1 | USD 49.6 M | Comprar |
1,657,365
+2,167
| +0.1% | +USD 58.7 k | ﹤0.01% | 2597 |
|
|
2021
Q4 | USD 43.9 M | Vender |
1,655,198
-18,032
| -1% | -USD 544 k | ﹤0.01% | 2744 |
|
|
2021
Q3 | USD 60.7 M | Vender |
1,673,230
-2,061
| -0.1% | -USD 81.1 k | ﹤0.01% | 2532 |
|
|
2021
Q2 | USD 72.7 M | Vender |
1,675,291
-85,025
| -5% | -USD 3.21 M | ﹤0.01% | 2451 |
|
|
2021
Q1 | USD 60.2 M | Comprar |
1,760,316
+10,974
| +0.6% | +USD 435 k | ﹤0.01% | 2506 |
|
|
2020
Q4 | USD 61.2 M | Comprar |
1,749,342
+29,898
| +2% | +USD 866 k | ﹤0.01% | 2357 |
|
|
2020
Q3 | USD 41.3 M | Vender |
1,719,444
-2,466
| -0.1% | -USD 60.5 k | ﹤0.01% | 2410 |
|
|
2020
Q2 | USD 31.5 M | Comprar |
1,721,910
+233,730
| +16% | +USD 4.2 M | ﹤0.01% | 2547 |
|
|
2020
Q1 | USD 23.2 M | Comprar |
1,488,180
+17,351
| +1% | +USD 369 k | ﹤0.01% | 2529 |
|
|
2019
Q4 | USD 31.5 M | Vender |
1,470,829
-13,746
| -0.9% | -USD 283 k | ﹤0.01% | 2631 |
|
|
2019
Q3 | USD 27.8 M | Comprar |
1,484,575
+93,873
| +7% | +USD 1.94 M | ﹤0.01% | 2623 |
|
|
2019
Q2 | USD 36.3 M | Vender |
1,390,702
-11,133
| -0.8% | -USD 251 k | ﹤0.01% | 2522 |
|
|
2019
Q1 | USD 36 M | Comprar |
1,401,835
+29,389
| +2% | +USD 672 k | ﹤0.01% | 2460 |
|
|
2018
Q4 | USD 31.6 M | Comprar |
1,372,446
+8,936
| +0.7% | +USD 252 k | ﹤0.01% | 2481 |
|
|
2018
Q3 | USD 43.8 M | Comprar |
1,363,510
+24,273
| +2% | +USD 729 k | ﹤0.01% | 2451 |
|
|
2018
Q2 | USD 37.9 M | Comprar |
1,339,237
+231,250
| +21% | +USD 8.23 M | ﹤0.01% | 2509 |
|
|
2018
Q1 | USD 39.2 M | Vender |
1,107,987
-14,580
| -1% | -USD 584 k | ﹤0.01% | 2412 |
|
|
2017
Q4 | USD 43.6 M | Comprar |
1,122,567
+192,500
| +21% | +USD 7.33 M | ﹤0.01% | 2375 |
|
|
2017
Q3 | USD 23.6 M | Vender |
930,067
-37,384
| -4% | -USD 909 k | ﹤0.01% | 2715 |
|
|
2017
Q2 | USD 26.4 M | Vender |
967,451
-48,964
| -5% | -USD 1.34 M | ﹤0.01% | 2636 |
|
|
2017
Q1 | USD 33.6 M | Comprar |
1,016,415
+1,014,258
| +47,022% | +USD 25.8 M | ﹤0.01% | 2447 |
|
|
2016
Q4 | USD 51 k | Vender |
2,157
-4,559
| -68% | -USD 131 k | ﹤0.01% | 2923 |
|
|
2016
Q3 | USD 247 k | Comprar |
6,716
+3,759
| +127% | +USD 108 k | ﹤0.01% | 2046 |
|
|
2016
Q2 | USD 66 k | Comprar |
2,957
+2,402
| +433% | +USD 59.7 k | ﹤0.01% | 2793 |
|
|
2016
Q1 | USD 11 k | Comprar |
555
+343
| +162% | +USD 8.46 k | ﹤0.01% | 3121 |
|
|
2015
Q4 | USD 6 k | Mantener |
212
| – | – | ﹤0.01% | 3097 |
|
|
2015
Q3 | USD 5 k | Mantener |
212
| – | – | ﹤0.01% | 3027 |
|
|
2015
Q2 | USD 7 k | Mantener |
212
| – | – | ﹤0.01% | 2998 |
|
|
2015
Q1 | USD 8 k | Mantener |
212
| – | – | ﹤0.01% | 2853 |
|
|
2014
Q4 | USD 5 k | Vender |
212
-72
| -25% | -USD 1.46 k | ﹤0.01% | 3072 |
|
|
2014
Q3 | USD 5 k | Mantener |
284
| – | – | ﹤0.01% | 3081 |
|
|
2014
Q2 | USD 11 k | Vender |
284
-46
| -14% | -USD 1.56 k | ﹤0.01% | 2726 |
|
|
2014
Q1 | USD 13 k | Mantener |
330
| – | – | ﹤0.01% | 2572 |
|
|
2013
Q4 | USD 9 k | Mantener |
330
| – | – | ﹤0.01% | 2793 |
|
|
2013
Q3 | USD 12 k | Mantener |
330
| – | – | ﹤0.01% | 2543 |
|
|
2013
Q2 | USD 11 k | Comprar |
+330
| Nuevas | +USD 15 k | ﹤0.01% | 2589 |
|
Otros fondos que tienen RIGL en su cartera
Posición de BlackRock en RIGL: resumen de T2 2026
BlackRock aumentó su participación en Rigel Pharmaceuticals (RIGL) en 9.7% durante T2 2026, al comprar aproximadamente USD 5.27 M y elevar la posición a 1,939,818 acciones con un valor de USD 75.9 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2389.
BlackRock reportó por primera vez una posición en RIGL en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 155 fondos que sigue Wall St. Rank mantienen una posición en RIGL.
- Al cierre de T2 2026, BlackRock tenía 1,939,818 acciones de Rigel Pharmaceuticals con un valor de USD 75.9 M.
- BlackRock compró 170,911 acciones de Rigel Pharmaceuticals en T2 2026, por un monto estimado de USD 5.27 M.
- Rigel Pharmaceuticals representó ﹤0.01% de la cartera de BlackRock en T2 2026 y fue su posición número 2389.
- BlackRock reportó por primera vez una posición en Rigel Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 155 fondos que sigue Wall St. Rank tenían Rigel Pharmaceuticals en cartera.
Según el Informe 13F de BlackRock correspondiente a T2 2026, presentado el 7 ago 2026.